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We report the successful use of high-frequency oscillatory ventilation without recruitment maneuvers in
a patient with ARDS and severe hypoxemia who developed a pneumomediastinum during conventional
mechanical ventilation. High-frequency ventilation is an attractive modality for the treatment of
pneumomediastinum, especially when the airway pressures cannot be reduced by variation in the
settings of the conventional mechanical ventilator.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Conventional mechanical ventilation, especially if large tidal
volumes are used, can lead to ventilator-induced lung injury (VILI)
in patients with adult respiratory distress syndrome. Pneumo-
mediastinum is one of the manifestations of VILI. The treatment of
pneumomediastinum in patients with ARDS can be challenging as
a result of the high airway pressures frequently observed during
conventional mechanical ventilation. High airway pressures may
lead to an increase in the amount of air collected in the medias-
tinum and produce hemodynamic instability. A reduction in the
airway pressures by using high-frequency oscillatory ventilation
(HFOV) is an attractive approach for the management of pneumo-
mediastinum in patients with ARDS.2. Case presentation
A 21-year-old Haitian woman, with an ideal body weight of
75 kg and known positive serology for human immunodeﬁciency
virus, presented with febrile syndrome and new inﬁltrates on the
chest radiography. In a matter of hours the patient developed adult
respiratory distress syndrome (ARDS) with severe hypoxemiccal Care.
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All rights reserved.respiratory failure that required intubation and mechanical venti-
lation (Figs. 1 and 2, panel A). Her initial settings were volume
control with a tidal volume of 600 ml (8 ml/kg), positive end
expiratory pressure (PEEP) of 18 cmH2O, fraction of inspired oxygen
100% and respiratory rate of 24 per minute. With this initial setting
the patient had high airway pressures (Peak pressure of 55 cmH2O,
Mean pressure of 26 cmH2O and Plateau pressure of 49 cmH20).
These high airway pressures, in part due to the relatively large tidal
volume used, led to the occurrence of pneumomediastinum and
subcutaneous emphysema. In spite several modiﬁcations of the
conventional ventilator parameters, including a rapid reduction of
the tidal volume to 5 ml/kg, the high airway pressures persisted
despite neuromuscular blockade and diverse manipulations of the
mechanical ventilator (different modes of ventilation, reduction of
the inspiratory ﬂow and inverse I/E ratio). In addition the patient’s
hypoxemia (PaO2/FIO2 91) aggravated. The patient remained
hemodynamically stable throughout the hospitalization and did
not develop a pneumothorax.
On the second day of hospitalization, prompted by worsening
oxygenation, the patient was placed on high-frequency oscillator
ventilation (HFOV) with mean pulmonary pressure of 24 cmH2O,
frequency 4.5 Hz, inspiratory time 33%, power 6, amplitude of
oscillation 74 cmH2O and FIO2 100%. Under the possibility of
increasing the pneumomediastinum, no recruitment maneuvers
were used. In a few days the subcutaneous emphysema and
pneumomediastinum (assessed by chest radiography) resolved.
Thereafter, the FIO2 and the mean pressure were decreased and 11
days later, the HFOV was discontinued and the patient was placed
on pressure control with inspiratory pressure of 18 cmH2O, PEEP
Fig. 1. Portable chest radiography, obtained during the second day of hospitalization, showing extensive alveolar inﬁltrates and pneumomediastinum (arrows) (Panel A). Four
weeks after the admission the chest radiography showed resolution of the inﬁltrates and pneumomediastinum (Panel B).
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lung inﬁltrates almost completely resolved (Figs. 1 and 2, panel B)
and she had adequate arterial blood gases on tracheostomy mask
with FIO2 28%. The etiology of the ARDS is uncertain as the patient
did not undergo necessary diagnostic studies due to her respira-
tory instability. Initial sputum culture only showed normal
respiratory ﬂora with negative fungal and acid fast bacilli (AFB)
stains and culture. Streptococcus pneumoniae, Legionella and
histoplasma urinary antigens were negative. She improved with
empiric treatment for Pneumocystis jirovecii and bacterial
pneumonia.
3. Discussion
Pneumomediastinum is manifestation of VILI and can occur in
patients with ARDS due to barotrauma. The progressive accumu-
lation of air in the mediastinum can lead to 1) hemodynamic
instability by reducing venous return and compromising cardiac
output, 2) atelectasis with potential increases in the airway pres-
sures, and 3) venous air embolism.1 Its prevention and manage-
ment include a reduction in the airway pressures by using a lung
protective strategy, however this strategy may lead to deterioration
of the already compromised oxygenation. Studies of HFOV in
patients with ARDS have being associated with improvements in
oxygenation when compared with conventional mechanical
ventilation, nevertheless a survival advantage of the former venti-
lator modality needs yet to be proven.2Fig. 2. Computed tomography of the chest without intravenous contrast showing extensive a
A). A second computed tomography obtained 4 weeks after the admission showed signiﬁ
subcutaneous emphysema.A potential application of HFVO is in the treatment of VILI. There
are case reports supporting the use of HFVO for tension pneuma-
tocele,3 bronchopleural ﬁstula4 and bilateral pneumothoraces with
persistent air leaks.5 A related condition, pneumomediastinum, can
be difﬁcult to treat in the context of patients with severe hypoxemia
due to ARDS, as the high airway pressure frequently observed with
conventional mechanical ventilation may aggravate the amount of
air collected in the mediastinum. An alternative approach is to use
HFOV, which is considered a lung protective ventilator strategy
mainly by two mechanisms. Firstly, it generates smaller tidal
volumes (1–2 ml/kg) at higher frequencies (>100 breath/min),
resulting in less alveolar overdistension and lower peak inspiratory
airway pressures. Secondly, oscillation provides adequate ventila-
tion at relatively high mean airway pressure with smaller pressure
variations, avoiding potentially injurious peak pressure and cyclical
alveolar collapse.6 Although animal studies have shown less
histological small airway and alveolar injury with the use of HFOV,7
in humans, the only two randomized controlled trials of HFOV
versus conventional mechanical ventilation showed no differences
in the rate of barotraumas between the treatment groups.8,9
Little is known about the use of HFVO for the treatment of ARDS
complicated with pneumomediastinum in adult patients. A review
of the literature revealed a successful treatment with HFOV with
recruitment maneuvers of ARDS complicated with pneumo-
mediastinum in an 18-month-old patient.1
Using HFOV without recruitment maneuvers, we successfully
treated an adult patient that developed severe hypoxemia due tolveolar inﬁltrates, pneumomediastinum (arrows) and subcutaneous emphysema (Panel
cant improvement of the inﬁltrates and resolution of the pneumomediastinum and
A.R. Tonelli et al. / Respiratory Medicine CME 2 (2009) 173–175 175ARDS, complicated by the occurrence of pneumomediastinum. The
patient required this mode of ventilation for several days due to
ARDS, whereas the pneumomediastinum rapidly resolved in a few
days of treatment.
4. Conclusion
High-frequency oscillatory ventilation without recruitment
maneuvers is a useful ventilatory modality in patients with severe
hypoxemia associated with ARDS and pneumomediatinum. Further
research is needed to support these ﬁndings.
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